Status:
UNKNOWN
Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)
Lead Sponsor:
Imelda Hospital, Bonheiden
Collaborating Sponsors:
Université Catholique de Louvain
Conditions:
Osteoporosis
Osteoarthritis, Hip
Eligibility:
All Genders
55+ years
Brief Summary
Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Com...
Eligibility Criteria
Inclusion
- Age 65 years and older
Exclusion
- known haematological condition (myelodysplasia, leukemia, cancer)
- inability to provide written informed consent
Key Trial Info
Start Date :
February 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05246813
Start Date
February 11 2022
End Date
December 31 2025
Last Update
March 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Imelda Hospital
Bonheiden, België, Belgium, 2820